Lightpoint: Case Study

RAISED, £3,273,597

INVESTORS, 100

FUNDED, 109%

RAISED

INVESTORS

FUNDED

£3,273,597

100

109%

In January 2017, VentureFounders successfully supported Lightpoint Medical in its £3.2 million equity raise, alongside angel investors and existing shareholders.

Lightpoint Medical is an innovative, clinical-stage medical device company that has developed a ground-breaking surgical imaging technology with the potential to detect cancer in real-time during surgery, and thereby reduce the need for re-operation. 

Cancerous tissue often fails to be completely removed during the initial surgery because there are no tools to rapidly and effectively detect cancer during surgery. Today, surgeons primarily rely on visual and tactile assessment to find microscopic cancerous deposits. Consequently, there is a tremendous medical need for improved tools to image cancerous tissue in real time during the operation.

Lightpoint Medical has developed a proprietary molecular imaging technology with the potential to detect cancer in real-time during surgery, and thereby reduce the need for re-operation. 

INVESTMENT HIGHLIGHTS

  • Sizeable market opportunity

  • Innovative product with market traction

  • Proprietary technology

  • Future product pipeline & licensing opportunities

  • Regulatory approval received

  • Significant funding received from a diversified investor base

  • Experienced management team & clinical expertise